RIGHT BG
A pharmacist displays a box of Plaquenil (hydroxychloroquine) at a drugstore in Paris, France, April 29, 2020. France on Wednesday banned the use of malaria drug hydroxychloroquine to treat patients suffering severe forms of COVID-19, the disease caused by the novel coronavirus. (Photo by Aurelien Morissard/Xinhua)
A box of Plaquenil (hydroxychloroquine) is seen at a drugstore in Paris, France, April 29, 2020. France on Wednesday banned the use of malaria drug hydroxychloroquine to treat patients suffering severe forms of COVID-19, the disease caused by the novel coronavirus. (Photo by Aurelien Morissard/Xinhua)
A box of Plaquenil (hydroxychloroquine) is seen at a drugstore in Paris, France, April 29, 2020. France on Wednesday banned the use of malaria drug hydroxychloroquine to treat patients suffering severe forms of COVID-19, the disease caused by the novel coronavirus. (Photo by Aurelien Morissard/Xinhua)
A pharmacist displays a box of Plaquenil (hydroxychloroquine) at a drugstore in Paris, France, April 29, 2020. France on Wednesday banned the use of malaria drug hydroxychloroquine to treat patients suffering severe forms of COVID-19, the disease caused by the novel coronavirus. (Photo by Aurelien Morissard/Xinhua)
